The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cevimeline-Global Market Insights and Sales Trends 2025
Synopsis
Cevimeline (trade name Evoxac) is a parasympathomimetic and muscarinic agonist, with particular effect on M1 and M3 receptors. It is used in the treatment of dry mouth and especially associated with Sjögren's syndrome.
The global Cevimeline market size is expected to reach US$ 325.3 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Cevimeline in various end use industries. The expanding demands from the Hospital and Drug Store, are propelling Cevimeline market. 20mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 30mg segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cevimeline market, driven by demand from China, the second largest economy with some signs of stabilising, the Cevimeline market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cevimeline, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cevimeline market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cevimeline market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cevimeline sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cevimeline covered in this report include Daiichi Sankyo, Novel Laboratories, Rising Pharmaceuticals, West-Ward Pharmaceuticals, Lupin and Sun Pharmaceutical, etc.
The global Cevimeline market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Daiichi Sankyo
Novel Laboratories
Rising Pharmaceuticals
West-Ward Pharmaceuticals
Lupin
Sun Pharmaceutical
Global Cevimeline market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cevimeline market, Segment by Type:
20mg
30mg
Global Cevimeline market, by Application
Hospital
Drug Store
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cevimeline manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cevimeline in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Cevimeline (trade name Evoxac) is a parasympathomimetic and muscarinic agonist, with particular effect on M1 and M3 receptors. It is used in the treatment of dry mouth and especially associated with Sjögren's syndrome.
The global Cevimeline market size is expected to reach US$ 325.3 million by 2029, growing at a CAGR of 6.1% from 2023 to 2029. The market is mainly driven by the significant applications of Cevimeline in various end use industries. The expanding demands from the Hospital and Drug Store, are propelling Cevimeline market. 20mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 30mg segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cevimeline market, driven by demand from China, the second largest economy with some signs of stabilising, the Cevimeline market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cevimeline, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cevimeline market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cevimeline market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cevimeline sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cevimeline covered in this report include Daiichi Sankyo, Novel Laboratories, Rising Pharmaceuticals, West-Ward Pharmaceuticals, Lupin and Sun Pharmaceutical, etc.
The global Cevimeline market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Daiichi Sankyo
Novel Laboratories
Rising Pharmaceuticals
West-Ward Pharmaceuticals
Lupin
Sun Pharmaceutical
Global Cevimeline market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cevimeline market, Segment by Type:
20mg
30mg
Global Cevimeline market, by Application
Hospital
Drug Store
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cevimeline manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cevimeline in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Cevimeline Market Overview
1.1 Cevimeline Product Overview
1.2 Cevimeline Market Segment by Type
1.2.1 20mg
1.2.2 30mg
1.3 Global Cevimeline Market Size by Type
1.3.1 Global Cevimeline Market Size Overview by Type (2018-2029)
1.3.2 Global Cevimeline Historic Market Size Review by Type (2018-2023)
1.3.3 Global Cevimeline Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cevimeline Sales Breakdown by Type (2018-2023)
1.4.2 Europe Cevimeline Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Cevimeline Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Cevimeline Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Cevimeline Sales Breakdown by Type (2018-2023)
2 Global Cevimeline Market Competition by Company
2.1 Global Top Players by Cevimeline Sales (2018-2023)
2.2 Global Top Players by Cevimeline Revenue (2018-2023)
2.3 Global Top Players by Cevimeline Price (2018-2023)
2.4 Global Top Manufacturers Cevimeline Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cevimeline Market Competitive Situation and Trends
2.5.1 Cevimeline Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Cevimeline Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cevimeline as of 2022)
2.7 Date of Key Manufacturers Enter into Cevimeline Market
2.8 Key Manufacturers Cevimeline Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cevimeline Status and Outlook by Region
3.1 Global Cevimeline Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Cevimeline Historic Market Size by Region
3.2.1 Global Cevimeline Sales in Volume by Region (2018-2023)
3.2.2 Global Cevimeline Sales in Value by Region (2018-2023)
3.2.3 Global Cevimeline Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Cevimeline Forecasted Market Size by Region
3.3.1 Global Cevimeline Sales in Volume by Region (2024-2029)
3.3.2 Global Cevimeline Sales in Value by Region (2024-2029)
3.3.3 Global Cevimeline Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Cevimeline by Application
4.1 Cevimeline Market Segment by Application
4.1.1 Hospital
4.1.2 Drug Store
4.2 Global Cevimeline Market Size by Application
4.2.1 Global Cevimeline Market Size Overview by Application (2018-2029)
4.2.2 Global Cevimeline Historic Market Size Review by Application (2018-2023)
4.2.3 Global Cevimeline Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cevimeline Sales Breakdown by Application (2018-2023)
4.3.2 Europe Cevimeline Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Cevimeline Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Cevimeline Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Cevimeline Sales Breakdown by Application (2018-2023)
5 North America Cevimeline by Country
5.1 North America Cevimeline Historic Market Size by Country
5.1.1 North America Cevimeline Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Cevimeline Sales in Volume by Country (2018-2023)
5.1.3 North America Cevimeline Sales in Value by Country (2018-2023)
5.2 North America Cevimeline Forecasted Market Size by Country
5.2.1 North America Cevimeline Sales in Volume by Country (2024-2029)
5.2.2 North America Cevimeline Sales in Value by Country (2024-2029)
6 Europe Cevimeline by Country
6.1 Europe Cevimeline Historic Market Size by Country
6.1.1 Europe Cevimeline Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Cevimeline Sales in Volume by Country (2018-2023)
6.1.3 Europe Cevimeline Sales in Value by Country (2018-2023)
6.2 Europe Cevimeline Forecasted Market Size by Country
6.2.1 Europe Cevimeline Sales in Volume by Country (2024-2029)
6.2.2 Europe Cevimeline Sales in Value by Country (2024-2029)
7 Asia-Pacific Cevimeline by Region
7.1 Asia-Pacific Cevimeline Historic Market Size by Region
7.1.1 Asia-Pacific Cevimeline Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Cevimeline Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Cevimeline Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Cevimeline Forecasted Market Size by Region
7.2.1 Asia-Pacific Cevimeline Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Cevimeline Sales in Value by Region (2024-2029)
8 Latin America Cevimeline by Country
8.1 Latin America Cevimeline Historic Market Size by Country
8.1.1 Latin America Cevimeline Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Cevimeline Sales in Volume by Country (2018-2023)
8.1.3 Latin America Cevimeline Sales in Value by Country (2018-2023)
8.2 Latin America Cevimeline Forecasted Market Size by Country
8.2.1 Latin America Cevimeline Sales in Volume by Country (2024-2029)
8.2.2 Latin America Cevimeline Sales in Value by Country (2024-2029)
9 Middle East and Africa Cevimeline by Country
9.1 Middle East and Africa Cevimeline Historic Market Size by Country
9.1.1 Middle East and Africa Cevimeline Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Cevimeline Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Cevimeline Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Cevimeline Forecasted Market Size by Country
9.2.1 Middle East and Africa Cevimeline Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Cevimeline Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Daiichi Sankyo
10.1.1 Daiichi Sankyo Company Information
10.1.2 Daiichi Sankyo Introduction and Business Overview
10.1.3 Daiichi Sankyo Cevimeline Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Daiichi Sankyo Cevimeline Products Offered
10.1.5 Daiichi Sankyo Recent Development
10.2 Novel Laboratories
10.2.1 Novel Laboratories Company Information
10.2.2 Novel Laboratories Introduction and Business Overview
10.2.3 Novel Laboratories Cevimeline Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novel Laboratories Cevimeline Products Offered
10.2.5 Novel Laboratories Recent Development
10.3 Rising Pharmaceuticals
10.3.1 Rising Pharmaceuticals Company Information
10.3.2 Rising Pharmaceuticals Introduction and Business Overview
10.3.3 Rising Pharmaceuticals Cevimeline Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Rising Pharmaceuticals Cevimeline Products Offered
10.3.5 Rising Pharmaceuticals Recent Development
10.4 West-Ward Pharmaceuticals
10.4.1 West-Ward Pharmaceuticals Company Information
10.4.2 West-Ward Pharmaceuticals Introduction and Business Overview
10.4.3 West-Ward Pharmaceuticals Cevimeline Sales, Revenue and Gross Margin (2018-2023)
10.4.4 West-Ward Pharmaceuticals Cevimeline Products Offered
10.4.5 West-Ward Pharmaceuticals Recent Development
10.5 Lupin
10.5.1 Lupin Company Information
10.5.2 Lupin Introduction and Business Overview
10.5.3 Lupin Cevimeline Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Lupin Cevimeline Products Offered
10.5.5 Lupin Recent Development
10.6 Sun Pharmaceutical
10.6.1 Sun Pharmaceutical Company Information
10.6.2 Sun Pharmaceutical Introduction and Business Overview
10.6.3 Sun Pharmaceutical Cevimeline Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Sun Pharmaceutical Cevimeline Products Offered
10.6.5 Sun Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cevimeline Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cevimeline Industrial Chain Analysis
11.4 Cevimeline Market Dynamics
11.4.1 Cevimeline Industry Trends
11.4.2 Cevimeline Market Drivers
11.4.3 Cevimeline Market Challenges
11.4.4 Cevimeline Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cevimeline Distributors
12.3 Cevimeline Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
